Penile shortening following radical prostatectomy and straightening procedures for Peyronie’s disease can be a devastating and unwelcome side effect of these operations. The majority of men undergoing radical prostatectomy for prostate cancer have a measured loss of penile length, which also can occur in men with Peyronie’s disease and may be exacerbated by surgery. Recent studies have investigated the mechanisms resulting in penile shortening, and various treatments have emerged to prevent and treat postoperative penile shortening. This article reviews the recent literature on penile length loss after radical prostatectomy and following correction of penile deformity for Peyronie’s disease.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
References and Recommended Reading
Savoie M, Kim SS, Soloway MS: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003, 169:1462–1464.
Munding MD, Wessells HB, Dalkin BL: Pilot study of changes in stretched penile length months after radical retropubic prostatectomy. J Urol 2001, 58:567–569.
Goodwin B, Brassil D, McCullough A: A 12 month interim analysis of the effect of nightly alprostadil vs sildenafil on penile morphometrics after nerve sparing radical prostatectomy. Presented at the Western Section American Urology Association Conference. Scottsdale, AZ; October 27–November 1, 2007.
Gontero P, Galzerano M, Bartoletti R, et al.: New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. J Urol 2007, 178:602–607.
McCullough A: Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve. Curr Urol Rep 2008, 9:492–499.
Mulhall JP: Penile length changes after radical prostatectomy. BJU Int 2005, 96:472–474.
Zhou S, Chen LS, Miyauchi Y, et al.: Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004, 95:76–83.
Moreland RB: Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998, 2:113–120.
Moreland RB, Traish A, McMillin MA, et al.: PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995, 153(3 Pt 1):826–834.
Leungwattanakij S, Bivalacqua TJ, Usta MF, et al.: Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003, 24:239–245.
Ciancio SJ, Kim ED: Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000, 85:101.
McCullough AR, Lepor H: The loss of penile length and circumference in impotent men after nerve sparing radical prostatectomy. J Urol 1988, 159:S98.
Kovanecz I, Rambhatla A, Ferrini MG, et al.: Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008, 101:203–210.
Kovanecz I, Rambhatla A, Ferrini M, et al.: Long-term continuous sildenafil treatment ameliorates corporal venoocclusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2008, 20:202–212.
Klein LT, Miller MI, Buttyan R, et al.: Apoptosis in the rat penis after penile denervation. J Urol 1997, 158:626–630.
Tuttle JB, Steers WD, Albo M, et al.: Neural input regulates tissue NGF and growth of the adult rat urinary bladder. J Auton Nerv Syst 1994, 49:147–158.
User HM, Hairston JH, Zelner DJ, et al.: Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003, 169:1175.
Iacono F, Giannella R, Somma P, et al.: Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005, 173:1673–1676.
Briganti A, Fabbri F, Salonia A, et al.: Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 2007, 52:702–707.
Tal R, Teloken PE, Mulhall JP: Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members. Presented at the American Urology Association Annual Meeting. Chicago, IL; April 28, 2009.
Raina R, Agarwal A, Zippe CD: Management of erectile dysfunction after radical prostatectomy. Urology 2005, 66:923–929.
Connor J, Sawczuk IS, Benson MC, et al.: Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate 1988, 13:119–130.
Dutta TC, Eid JF: Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. J Urol 1999, 54:891–893.
Kökler TS, Pedro R, Hendlin K, et al.: A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007, 100:858–862.
Dalkin BL, Christopher BA: Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device. Int J Impot Res 2007, 19:501–504.
Gontero P, Di Marco M, Giubilei G, et al.: Use of penile extender device in the treatment of penile curvature as a result of Peyronie’s disease. Results of a phase II prospective study. J Sex Med 2009, 6:558–566.
Levine LA, Newell MM: FastSize medical extender for the treatment of Peyronie’s disease. Expert Rev Med Devices 2008, 5:305–310.
Vardi Y, Levine LA, Chen J, et al.: Is there a place for conservative treatment in Peyronie’s disease? J Sex Med 2009, 6:903–909.
Ralph D: Peyronie’s Disease: A Guide to Clinical Management, vol 12. New York: Humana Press; 2007:133–144.
Schneider T, Sperling H, Schenck M, et al.: Treatment of penile curvature: how to combine the advantages of simple plication and the Nesbit-procedure by superficial excision of the tunica albuginea. World J Urol 2003, 20:350–355.
Kalsi J, Minhas S, Christopher N, Ralph D: The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie’s disease. BJU Int 2005, 95:1029–1033.
Syed AH, Abbasi Z, Hargreave TB: Nesbit procedure for disabling Peyronie’s curvature: a median follow-up of 84 months. J Urol 2003, 61:999–1003.
Gholami SS, Lue TF: Correction of penile curvature using the 16-DOT plication technique: a review of 132 patients. J Urol 2002, 167:2066–2069.
Levine LA: Peyronie’s Disease: A Guide to Clinical Management. New York: Humana Press; 2007:133–151.
Sajadi KP, Spears B, Shah SA, et al.: The Yachia corporoplasty for Peyronie’s disease: a single-institution 9 year experience. J Urol 2008, 179(Suppl):408.
Daitch JA, Angermeier KW, Montague DK: Modified corporoplasty for penile curvature: long-term results and patient satisfaction. J Urol 1999, 162:2006–2009.
Savoca G, Scieri F, Pietropaolo F, et al.: Straightening corporoplasty for Peyronie’s disease: a review of 218 patients with median follow-up of 89 months. Eur Urol 2004, 46:610–614; discussion 613–614.
Hatzichristou DG, Hatzimouratidis K, Apostolidis A, et al.: Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long-term results. J Urol 2002, 167:1367–1370.
Lue TF, El-Sakka AI: Venous patch graft for Peyronie’s disease. Part I: technique. J Urol 1998, 160:2047–2049.
Adeniyi AA, Goorney SR, Pryor JP, et al.: The Lue procedure: an analysis of the outcome in Peyronie’s disease. BJU Int 2002, 89:404–408.
Kalsi J, Minhas S, Christopher N, et al.: The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie’s disease. BJU Int 2005, 95:1029–1033.
Knoll DL: Use of small intestinal submucosa graft for the surgical management of Peyronie’s disease. J Urol 2007, 178:2474–2478.
Greenfield JM, Lucas S, Levine LA: Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol 2006, 175:238–241.
Levine LA, Lenting EL: A surgical algorithm for the treatment of Peyronie’s disease. J Urol 1997, 158:2149–2152.
Alenghat FJ, Ingber DE: Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE 2002, 12:PE6.
Hayashi K: Biomechanical studies of the remodeling of knee joint tendons and ligaments. J Biomech 1996, 29:707–716.
Messina A, Messina J: The continuous elongation treatment by the TEC device for severe Dupuytren’s contracture of the fingers. Plast Reconstr Surg 1993, 92:84–90.
Gontero P, Di Marco M, Giubilei G, et al.: A pilot phase-II prospective study to test the “efficacy” and tolerability of a penile-extender device in the treatment of “short penis.” BJU Int 2009, 103:793–797.
Levine LA, Newell M, Taylor FL: Penile traction therapy for treatment of Peyronie’s disease: a single-center pilot study. J Sex Med 2008, 5:1468–1473.
Lue TF, El-Sakka AI: Lengthening shortened penis caused by Peyronie’s disease using circular venous grafting and daily stretching with a vacuum erection device. J Urol 1999, 161:1141–1144.
Moncada-Iribarren I, Jara J, Martinez-Salamanca JI, et al.: Managing penile shortening after Peyronie’s disease surgery. J Urol 2007, 177(Suppl 4):252.
Levine LA, Greenfield JM, Estrada CR: Erectile dysfunction following surgical correction of Peyronie’s disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med 2005, 2:241–247.
About this article
Cite this article
Benson, J.S., Abern, M.R. & Levine, L.A. Penile shortening after radical prostatectomy and Peyronie’s surgery. Curr Urol Rep 10, 468 (2009). https://doi.org/10.1007/s11934-009-0074-z
- Erectile Dysfunction
- Radical Prostatectomy
- Radical Retropubic Prostatectomy
- Penile Length
- Penile Curvature